Journal
CNS SPECTRUMS
Volume 13, Issue 9, Pages 752-756Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1017/S1092852900013869
Keywords
-
Categories
Funding
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Lundbeck A/S
- Orion
- Pfizer
- Pharmacia
- Roche
- Servier
- Solvay
- Sumitomo
- Wyeth
- Medical Research Council of South Africa
Ask authors/readers for more resources
There is controversy about whether mindfulness-based approaches to psychotherapy represent a new wave of cognitive-behavioral therapy or a core process in all psychotherapies. One way of conceptualizing mindfulness is in terms of emotion regulation; mindfulness is a strategy aimed at opposing suppression and avoidance. Dispositional mindfulness has been associated with greater activation in prefrontal cortex and greater deactivation of amygdala during affect labeling. A number of rigorous studies of mindfulness-based cognitive therapy for depression have been positive. However, much remains to be discovered about the underlying mechanisms of and clinical indications for mindfulness-based approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available